Latest Articlesddd
Prohost Letter #387 Topic of the Week DUCHENNE MUSCULAR DYSTROPHY Which Firms Will Get It Right …
To shareholders who were stupefied with an instigated selloff of Incyte’s (INCY) stock today, we say …
– Shire to Acquire Dyax for $5.9million and some possible extras. – Angioedema market has treatments …
Prohost Letter #386 An Evaluation of Prohost Picks and Some Other Interesting Biotechnology Companies (Part 2) …
Another Durable Botulinum Toxin with Many Advantages REVANCE THERAPEUTICS As per its self- described profile, Revance …
POSITIVE TOP-LINE RESULTS FROM A PHASE 2 TRIAL OF OMECAMTIV MECARBIL IN PATIENTS WITH CHRONIC HEART FAILURE …
The FDA issued a warning that hepatitis C treatment Viekira Pak and Technivie can cause serious …
– Exelixis submitted rolling NDA for cabozantinib. – Exelixis plans to complete the submission in the …
Prohost Letter #385 An Evaluation of Prohost Picks and Some Other Interesting Biotechnology Companies The Top-Tier …
About Duchenne muscular Dystrophy treatments, bloggers tried to explain the reasons that led the FDA to …
Incyte (INCY) and Merck (MRK) announced the expansion of their ongoing clinical collaboration to include a Phase …
Stories from Yesterday’s Market We are not claiming that the market volatility has subsided and the …
Prohost Letter #384 The Assassination of the Biotech Sector The Market (Part 2) On Friday September 18, …
– Exclusively licenses global rights to its (TGFb) antibody program to Novartis – Could the lucrative …
Exelixis (EXEL) announced positive results from the METEOR Phase 3 Pivotal Trial of Cabozantinib in advanced …
Prohost Letter #383 The Market - Recent tails about the market and the biotech sector are true …
Aerie Pharmaceuticals (AERI), which is specialized in glaucoma treatments reported successful results of its second Phase …
The biotechnology industry is proving to be the most innovative and the most growing among Wall …
– The second approval of a cancer drug for Exelixis – The approval of Exelixis/Roche drugs …
A Letter From Prohost The Stock Market Selloff What’s Going On and What Do We Do …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
